Artículos por temáticas

Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study

Lebedev AV, Beyer MK, Fritze F, Westman E, Ballard C, Aarsland D.

Am J Geriatr Psychiatry. 2014 Jan;22(1):4-13.e1. doi: 10.1016/j.jagp.2013.02.004. Epub 2013 Jul 20.

[Recent development of non-steroidal anti-inflammatory drugs on the neuro-inflammation of Alzheimer's disease]

Ma XW, Li JZ, Zhang TT, Du GH.

Yao Xue Xue Bao. 2014 Sep;49(9):1211-7.

[The influence of anosognosia and depression on the perceived quality of life of patients with Alzheimer's disease: a 12 months follow-up]

Portellano-Ortiz C, Turró-Garriga O, Gascón-Bayarri J, Piñán-Hernández S, Moreno-Cordón L, Viñas-Díez V, Reñé-Ramírez R, Conde-Sala JL.

Rev Neurol. 2014 Sep 1;59(5):193-204.

A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects

Grimaldi LM, Zappalà G, Iemolo F, Castellano AE, Ruggieri S, Bruno G, Paolillo A.

J Neuroinflammation. 2014 Feb 13;11:30. doi: 10.1186/1742-2094-11-30.

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial

Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N.

Clin Interv Aging. 2014 Jun 18;9:947-61. doi: 10.2147/CIA.S65625. eCollection 2014.

A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease

Grove RA, Harrington CM, Mahler A, Beresford I, Maruff P, Lowy MT, Nicholls AP, Boardley RL, Berges AC, Nathan PJ, Horrigan JP.

Curr Alzheimer Res. 2014 Jan;11(1):47-58. doi: 10.2174/1567205010666131212110148.

Parallel improvement of cognitive functions and P300 latency following donepezil treatment in patients with Alzheimer's disease: a case-control study

Chang YS, Chen HL, Hsu CY, Tang SH, Liu CK.

J Clin Neurophysiol. 2014 Feb;31(1):81-5. doi: 10.1097/01.wnp.0000436899.48243.5e.

Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid

Beach TG, Schneider JA, Sue LI, Serrano G, Dugger BN, Monsell SE, Kukull W.

J Neuropathol Exp Neurol. 2014 Oct;73(10):948-53. doi: 10.1097/NEN.0000000000000114.

A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia

Haig GM, Pritchett Y, Meier A, Othman AA, Hall C, Gault LM, Lenz RA.

J Alzheimers Dis. 2014;42(3):959-71. doi: 10.3233/JAD-140291.

Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product

Sadhu A, Upadhyay P, Agrawal A, Ilango K, Karmakar D, Singh GP, Dubey GP.

Clin Drug Investig. 2014 Dec;34(12):857-69. doi: 10.1007/s40261-014-0235-9.

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study

Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ; AV45-A11 Study Group;

Mol Psychiatry. 2014 Sep;19(9):1044-51. doi: 10.1038/mp.2014.9. Epub 2014 Mar 11.

Auditory hallucinations associated with nitrofurantoin use: case report and review of the literature

Štuhec M.

Wien Klin Wochenschr. 2014 Sep;126(17-18):549-52. doi: 10.1007/s00508-014-0577-6. Epub 2014 Aug 15.

The Quick Mild Cognitive Impairment screen correlated with the Standardized Alzheimer's Disease Assessment Scale-cognitive section in clinical trials

O'Caoimh R, Svendrovski A, Johnston BC, Gao Y, McGlade C, Eustace J, Timmons S, Guyatt G, Molloy DW.

J Clin Epidemiol. 2014 Jan;67(1):87-92. doi: 10.1016/j.jclinepi.2013.07.009. Epub 2013 Sep 25.

Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial

Lanctôt KL, Chau SA, Herrmann N, Drye LT, Rosenberg PB, Scherer RW, Black SE, Vaidya V, Bachman DL, Mintzer JE.

Int Psychogeriatr. 2014 Feb;26(2):239-46. doi: 10.1017/S1041610213001762. Epub 2013 Oct 29.

A brief report on the efficacy of donepezil in pain management in Alzheimer's disease

Gharaei H, Shadlou H.

J Pain Palliat Care Pharmacother. 2014 Mar;28(1):37-9. doi: 10.3109/15360288.2013.876484. Epub 2014 Jan 23.